Investegate |Beximco Pharmaceut Announcements | Beximco Pharmaceut: Results for the 12-month period ended 30 June 2022

Investegate announcements from Beximco Pharmaceut, Results for the 12-month period ended 30 June 2022

Related Keywords

Georgia , United States , Australia , Bangladesh , India , United Kingdom , Morocco , East Timor , Canada , Ukraine , America , Timor , Foster Mitchell , Mohammad Ali Nawaz , Mark Brady Andrew , Oxford Astrazeneca , Asia Pacific , Vadim Alexandre Abigail Wayne , Beximco Pharma , Beta Cardone Sotalol , Sm Rabbur Reza , Beximco Pharmaceuticals , United Kingdom Company , Beximco Pharmaceuticals Limited Pharma , Owners Of The Company , Advisory Partners Limited Nominated Adviser , Sp Angel Corporate Finance , Sanofi Bangladesh , Cash Equivalents Of Synovia Pharma , Serum Institute Of India , Synovia Pharma , Exchange Rate Changesoncash , Market Abuse Regulation , English Law , Pharmaceuticals Limited , Bangladesh Taka , Sanofi Bangladesh Limited , Phenergan Plus , Serum Institute , United Nations Backed Medicines Patent Pool , Global Generics , Biosimilars Awards , Won Global Generics , Olopatadine Eye Drop , Received Marketing Authorizations , Quinine Bisulphate , Nazmul Hassan , Chief Operating , Ali Nawaz , Chief Financial , Partners Limited , Nominated Adviser , Victoria Foster , Latin America , Issue Price , Face Value , Term Borrowings Net , Before Contribution , Comprehensiveincome Attributable , Per Share , Year Ended June , Depreciationon Revalued , Deferred Taxon Revalued , Asset Value , Investing Activities , Financing Activities , Long Term , Short Term , Cash Equivalents , Includes Cash , Investegate Announcements , Investegate Company Announcements , Beximco Pharmaceut , Egulatory News Service , Egulatory News Service And Regulatory , Ns ,